Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212 (original) (raw)

References

• Ashkenazi, A. and Dixit, V. M., Death receptors: signaling and modulation. Science, 287, 1305–1308 (1998).
  Article Google Scholar
• Choi, S. S., Kang, B. Y., Chung, M. J., Kim, S. D., Park, S. H., Kim, J. S., Kang, C. Y., and Ha, N. J., Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans. J. Microbiol., 43, 493–498 (2005).
  PubMed CAS Google Scholar
• de la Chapelle, A., Genetic predisposition to colorectal cancer. Nat. Rev. Cancer, 4, 769–780 (2004).
  Article PubMed CAS Google Scholar
• Fernandes, C. F. and Shahani, K. M., Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Prot., 53, 704–710 (1990).
  Google Scholar
• Goldin, B. R. and Gorbach, S. L., The relationship between diet and rat fecal bacterial enzymes. J. Natl. Cancer Inst, 57, 371–375 (1976).
  PubMed CAS Google Scholar
• Gomez, E., Melar, M. M., Silva, G. P., Portoles, A., and Gil, I., Exocellular products from Bifidobacterium adolescentis as immunomodifiers in the lymphoproliferative responses of mouse splenocytes. FEMS. Microbiol. Lett., 56, 47–52 (1998).
  Article Google Scholar
• Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M., Cancer statistics. CA Cancer J. Clin, 51, 144 (2001).
  Google Scholar
• Kado-Oka, Y., Fujiwara, S., and Hirota, T., Effects of bifidobacteria cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenshaft, 46, 626–630 (1991).
  Google Scholar
• Kim, D. H., Kang, H. J., Kim, S. W., and Kobayashi, K., pH-inducible β-glucuronidase and β-glucosidase of intestinal bacteria. Chem. Pharm. Bull., 40, 1967–1969 (1992).
  Google Scholar
• Kim, D. H., Lee, J. H., Bae, E. A., and Han, M. J., Induction and inhibition of indole of intestinal bacteria. Arch. Pharm. Res., 18, 351–355 (1995).
  Article CAS Google Scholar
• Lee, J., Ametani, A., Enomoto, A., Sato, Y., Motoshima, H., Ike, R., and Kaminogawa, S., Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by Bifidobacterium adolescentis M101-4, Biosci. Biotech. Biochem., 57, 2127–2132 (1993).
  CAS Google Scholar
• Maclennan, R. and Jensen, O. M., Dietary fibre, transit time, fecal bacteria, steroids and colon cancer in two Scandiavian populations. Lancet, 30, 207–211 (1977).
  Google Scholar
• Malhotra, S. L., Dietary factors in a study of colon cancer from Cancer Registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre. Med. Hypotheses, 3, 122–126 (1977).
  Article PubMed CAS Google Scholar
• Manjunath, N. and Ranganathan, B., A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumor cells. Indian J. Exp. Biol., 27, 141–145 (1989).
  PubMed CAS Google Scholar
• Natoli, G., Costanzo, A., Guido, F., Moretti, F., and Lovreto, M., Apoptotic, non-apoptotic and anti-apoptotic pathways of TNF signaling. Biochem. Pharmacol., 56, 915–920 (1998).
  Article PubMed CAS Google Scholar
• Oda, M., Hasegawa, H., Komatsu, S., Kambe, M., and Tsuchiya, F., Anti-tumor polysaccharide from Lactobacillus sp. Agric. Biol. Chem., 47, 1623–1625 (1983).
  CAS Google Scholar
• Pisani, P., Parkin, D. M., and Ferlay, J., Estimates of the worldwide mortality from eighteen major cancers in 1985. Int. J. Cancer, 54, 594–606 (1993).
  Article PubMed Google Scholar
• Rafter, J. J., The role of lactic acid bacteria in colon cancer prevention. Scand. J. Gastroenterol., 30, 497–502 (1995).
  Article PubMed CAS Google Scholar
• Reddy, B. S., Nutritional factors and colon cancer. Crit. Rev. Fd. Sci. Nutr., 35, 175–190 (1995).
  Article CAS Google Scholar
• Reddy, B. S. and Wynder, E., Metabolic epidemiology of colorectal cancer: fecal bile acids and neutral steroids in colon cancer patients with adenomatous polyps. Cancer, 39, 2533–2539 (1977).
  Article PubMed CAS Google Scholar
• Scardovi, V., Genus Bifidobacterium, p. 1418–1434. In N.R. Krieg and J. G. Holt (ed.), Bergey’s Manual of Systemic Bacteriology, vol. 2, Williams & Willikins, MD (1986).
  Google Scholar
• Sekine, K., Ohta, J., Onishi, M., Tatsuki, T., Shimokawa, Y., Toida, T., Kawashima, T., and Hashimoto, Y., Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol. Pharm. Bull., 18, 148–153 (1995).
  PubMed CAS Google Scholar
• Sekine, K., Watanabe-Sekine, E., Toida, T., Kasashima, T., Kataoka, T., and Hashimoto, Y., Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice. Immunopharmacol. Immunotoxicol., 16, 589–609 (1994).
  Article PubMed CAS Google Scholar
• Shahani, K. M. and Ayebo, A. D., Role of dietary lactobacilli in gastrointestinal microecology. Am. J. Clin. Nutr., 33, 2448–2457 (1980).
  PubMed CAS Google Scholar
• van Faassen, A., Bol, J., van den Brandt, van den Bogaard, Hermus, R. J. J., and Janknegt, R. A., Bile acids and pH values in total feces and fecal water from habitually omnivorous and vegetarian subjects. Am. J. Clin. Nutr., 58, 917–922 (1993).
  PubMed Google Scholar
• Lee, W. K. and Lee, S. M., Inhibition effects of Lactic acid bacteria (LAB) on the Azoxymethance-induced colonic preneoplastic lesions. J. Microbiol., 38, 169–175 (2000).
  Google Scholar
• Williams, R. T., Toxicological implications of biotransformation by intestinal microflora. Toxicol. Appl. Pharmacol., 23, 769–781 (1972).
  Article PubMed CAS Google Scholar

Download references